“…The most common form of vesicular nanoparticle is the liposome (Bunker et al, 2016), a vesicle formed from naturally occurring phospholipids. Other amphiphilic molecules formed into vesicles are, however, also used in drug delivery, including ethosomes (Touitou et al, 2000), niosomes (Marianecci et al, 2014;Khan and Irchhaiya, 2016;Chen S. et al, 2019;Kapoor et al, 2019;Khalkhali et al, 2019;Inglut et al, 2020), polymersomes (Aibani et al, 2020;Khan et al, 2020), exosomes (Antimisiaris et al, 2018;Villa et al, 2019;Chung et al, 2020;Rahmati et al, 2020), ufasomes (Han, 2013), and drimersomes (Nummelin et al, 2017), comprehensive reviews have been written about vesicle formation (Šegota and Durdica, 2006) and application in drug delivery (Kapoor et al, 2019) in a general context. Polymers and lipids can be formed into other structures than micelles or vesicles, for example two different polymers can be used to form core-shell structures (Ramli et al, 2013;Abbott et al, 2017;Chen G. et al, 2018), for example a solid outer shell with a liquid polymer with drug encapsulated inside; solid lipid nanoparticles (Beloqui et al, 2016;Gordillo-Galeano and Mora-Huertas, 2018;Subramaniam et al, 2020), chitosan (Bernkop-Schnürch and Dünnhaupt, 2012), lipoplex (Scheideler et al, 2020) and other lipid-polymer nanoparticles (Date et al, 2018) have also been proposed.…”